Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Indapamide adverse reaction |
Causative agent (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to indapamide |
Causative agent (attribute) |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Indapamide 1.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely indapamide 2.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely indapamide 1.25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Perindopril erbumine+indapamide 4mg/1.25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing indapamide and perindopril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to indapamide |
Causative agent (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Indapamide hemihydrate (substance) |
Is a |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely indapamide 2.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely indapamide 2.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely indapamide 1.25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely indapamide 1.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide 1.5 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Indapamide 1.5 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing indapamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely indapamide 1.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely indapamide 2.5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing indapamide and perindopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide hemihydrate (substance) |
Is modification of (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only indapamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Indapamide and perindopril only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only indapamide and perindopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely indapamide (as indapamide hemihydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing amlodipine and indapamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amlodipine and indapamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing amlodipine and indapamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only amlodipine and indapamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amlodipine (as amlodipine besilate) 2.5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amlodipine (as amlodipine besilate) 2.5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely indapamide 625 microgram and perindopril tosilate 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely indapamide 625 microgram and perindopril tosilate 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide 625 microgram and perindopril arginine 2.5 mg oral tablet |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide 625 microgram and perindopril arginine 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide 2.5 mg and perindopril arginine 10 mg oral tablet |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Indapamide 2.5 mg and perindopril arginine 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.25 mg and perindopril arginine 5 mg oral tablet |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.25 mg and perindopril arginine 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing amlodipine and indapamide and perindopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Amlodipine and indapamide and perindopril only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Amlodipine and indapamide and perindopril only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing amlodipine and indapamide and perindopril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 2.5 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 2.5 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and indapamide 2.5 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and indapamide 2.5 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Indapamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |